Latest filing published 20 Aug 2021 for Propanc Biopharma, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Andrew Nathanielsz: trading record in brief
This profile gathers the share dealings of James Andrew Nathanielsz in Propanc Biopharma, Inc., where the filings describe the role as finance chief. Over a trading history stretching from 23 August 2012 to 17 August 2021, the count stands at 9 filings.
In open-market terms, that means 1 purchase worth €40k on one side and 5 sales worth €48k on the other. Netting one side against the other leaves €7,810 of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
The record was last updated on 20 August 2021 with a share grant in Propanc Biopharma, Inc. The last insider purchase was made public on 24 August 2012, 5,189 days ago. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Andrew Nathanielsz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,800,000 shares0Common stock, par value $0.001SEC:0001493152-21-020758:1
- 5,928,000 shares0Common stock, par value $0.001SEC:0001493152-21-020758:0
- 33,259,350 sharesCommon Stock, par value $0.001SEC:0000891839-16-000266:0
- 250,000 shares@ US$0.20Common stock, par value $0.001 per shareSEC:0001144204-15-001926:0
- 5,000 shares@ US$0.20Common stock, par value $0.001 per shareSEC:0001144204-15-001926:1
- 5,500 shares@ US$0.20Common stock, par value $0.001 per shareSEC:0001144204-15-001926:2
- 15,000 shares@ US$0.20Common stock, par value $0.001 per shareSEC:0001144204-15-001926:3
- 55,000 shares@ US$0.0906Common stock, par value $0.001 per shareSEC:0001144204-15-001926:4
- 250,000 shares@ US$0.20Common StockSEC:0001354488-12-004546:0Canonical exit: 21 Nov 2012 (T+90)
9 of 9 declarations